Moxifloxacin Hydrochloride Tablets, 400 Mg Tablet, Film Coated
Product Images NDC 72205-001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Moxifloxacin Hydrochloride Tablets, 400 Mg (NDC 72205-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
30s-label (Moxifloxacin 30s Container Label)
This is a label for a pack of Moxifloxacin Tablets with a strength of 400mg. The label contains information about the medication, dosage, administration, and storage. It also instructs pharmacists to dispense an accompanying medication guide to patients. The tablets are manufactured by MSN Laboratories in India and distributed by Novadoz Pharmaceuticals LLC in the USA. The label also includes details about manufacturing and distribution, as well as a batch number and expiry date which should be encoded for tracking purposes.*
500s-label (Moxifloxacin 500s Container Label)
This is a description of a medication called Moxifloxacin. The medication contains 400 mg of Moxifloxacin Hydrochloride USP and is available in tablet form. The recommended dosage and administration instructions can be found in the accompanying literature. The medication should be stored at a temperature between 25°C (77°F) and 30°C (86°F). The manufacturer of the medication is MSN Laboratories Private Limited based in Telangana, India, and it is distributed by Novadoz Pharmaceuticals in Piscataway, New Jersey. The medication guide should be dispensed to each patient. The description contains manufacturing and expiration details.*
Carton-label (Moxifloxacin Carton Label)
This is a description of Moxifloxacin Tablets, USP, with 50 (5 X 10) unit-dose tablets contained in each package. Each tablet contains moxifloxacin hydrochloride USP equivalent to 400 g of moxifoxacin. The accompanying medication guide must be dispensed to each patient. The tablets are intended for institutional use only, and proper dosage instructions should be followed. The manufacturer is MSN Laboratories Private Limited, Telangana - 509 228, INDIA, and the distributor is Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. The lot number is XXO000000K, and the packaging must be coded with 2D during packing. Storage temperature should be at 25°C (77°F), with excursions permitted to 15°-30°C (59°-86°F).*
Blister-foil (Moxifloxacin Foil)
This is a description of a medication called Moxifloxacin Tablet, USP. The text includes the National Drug Codes (NDC) for the medication and mentions the manufacturer as MSN Laboratores Private Limited. However, there is some jumbled text and symbols making the information difficult to read and understand.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.